Working… Menu

Liver Cancer Immunotherapy: Placebo-controlled Clinical Trial of Hepcortespenlisimut-L (Hepko-V5)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02232490
Recruitment Status : Unknown
Verified February 2019 by Aldar Bourinbaiar, Immunitor LLC.
Recruitment status was:  Recruiting
First Posted : September 5, 2014
Last Update Posted : February 26, 2019
Information provided by (Responsible Party):
Aldar Bourinbaiar, Immunitor LLC

No Study Results Posted on for this Study
Recruitment Status : Unknown
Estimated Primary Completion Date : November 2019
Estimated Study Completion Date : December 2019